Allergenspezifische Immuntherapie bei Rhinitis allergica

Reply

(2014) Hans-Jørgen Malling et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Intralymphatic immunotherapy: Time interval between injections is essential

(2014) Thomas M. Kündig et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen

(2013) J. Kleine-Tebbe et al.   ALLERGOLOGIE

Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?

(2013) Marianne Witten et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis

(2013) Terese Hylander et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

(2011) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A century of immunotherapy

(2010) J. O. Warner   PEDIATRIC ALLERGY AND IMMUNOLOGY

Intralymphatic immunotherapy

(2009) Gabriela Senti et al.   Current Opinion in Allergy and Clinical Immunology

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy

(2009) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial

(2008) Sarah A Frech et al.   LANCET

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

(2008) G. Senti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch

(2008) David M. Frerichs et al.   VACCINE